All publications
A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations
Pharmaceutics 2021, 13, 2107 https://doi.org/10.3390/pharmaceutics13122107 - Dec 2021
A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics
Pharmaceutical Research volume 36, Article number: 102 doi: 10.1007/s11095-019-2639-y. - May 2019
In this study, the authors show that solid SMEDDS can be produced with a 3D printing process and solid and semi-solid lipid excipients. The proof of concept is established with cinnarizine and fenofibrate as model drugs.
An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems
Pharmaceutical Research volume 36, Article number: 4 doi: 10.1007/s11095-018-2531-1. - Nov 2018
In this review article, the authors describe the various technologies used for 3D printing and their application in the pharmaceutical field.
The potential for lipids and the opportunities for lipid-based drug delivery systems are highlighted.